Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of over-the-counter (OTC) Diclofenac Sodium Topical Gel 1%, the store brand version of Novartis’ Voltaren Arthritis Pain in the U.S. market.
Since the launch in May, Voltaren had total U.S. retail sales of ~$44M, according to IRI.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.